Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Cell Med
Autori principali: Naderi, Malihe, Gholipour, Naghmeh, Zolfaghari, Mohammad Reza, Moradi Binabaj, Maryam, Yegane Moghadam, Ahmad, Motalleb, Gholamreza
Natura: Artigo
Lingua:Inglês
Pubblicazione: Babol University of Medical Sciences 2014
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293608/
https://ncbi.nlm.nih.gov/pubmed/25635247
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi